Company Filing History:
Years Active: 2025
Title: Sarah Batey: Innovator in Antibody Molecules
Introduction
Sarah Batey is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biotechnology, particularly in the development of antibody molecules that have the potential to treat diseases such as cancer. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Sarah Batey holds a patent for "Antibody molecules that bind PD-L1 and CD137." This patent describes antibody molecules that can bind both PD-L1 and CD137, inducing agonism of CD137. The design of these antibody molecules includes a CDR-based binding site for PD-L1 and a CD137 antigen-binding site located in a constant domain of the antibody molecule. This invention has promising applications in the treatment of various diseases, particularly cancer.
Career Highlights
Throughout her career, Sarah has worked with notable companies in the biotechnology sector, including Invox Pharma Limited and F-star Biotechnology Ltd. Her experience in these organizations has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Sarah has collaborated with talented individuals such as Matthew Lakins and Jose Munoz-Olaya. These partnerships have enriched her work and fostered an environment of innovation and creativity.
Conclusion
In summary, Sarah Batey is an accomplished inventor whose work in antibody molecules has the potential to make a significant impact in the treatment of cancer. Her dedication to research and collaboration highlights her role as a key figure in the biotechnology industry.